Organon & Co. — Investor Relations & Filings
Filings indexed
399
across all filing types
Latest filing
2026-05-29
Regulatory Filings
Country
US
United States of America
Listing
US
OGN
Organon & Co. is a global healthcare company dedicated to improving the health of women. The company's portfolio is structured around three core pillars: Women's Health, Biosimilars, and Established Brands. The Women's Health division focuses on reproductive health, including contraception and fertility, as well as other conditions unique to women. The Biosimilars business aims to provide more accessible treatment options, particularly in oncology and immunology. The Established Brands unit manages a diverse range of therapies for conditions such as cardiovascular disease, respiratory illnesses, dermatology, and neurology. Organon's portfolio includes more than 70 medicines and devices, which are available in over 140 markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM SD | 2026-05-29 | English | |
| 10-Q - Organon & Co. (0001821825) (Filer) | 2026-05-04 | English | |
| 8-K - Organon & Co. (0001821825) (Filer) | 2026-04-30 | English | |
| 8-K - Organon & Co. (0001821825) (Filer) | 2026-04-27 | English | |
| 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | |
| 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 47882447 | FORM SD | 2026-05-29 | English | ||
| 40904289 | 10-Q - Organon & Co. (0001821825) (Filer) | 2026-05-04 | English | ||
| 39076594 | 8-K - Organon & Co. (0001821825) (Filer) | 2026-04-30 | English | ||
| 37390208 | 8-K - Organon & Co. (0001821825) (Filer) | 2026-04-27 | English | ||
| 32899042 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899043 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899041 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899046 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899044 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899047 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899053 | 10-K - ORGANON & CO. (0001821825) (Filer) | 2026-02-24 | English | ||
| 32899049 | 8-K - ORGANON & CO. (0001821825) (Filer) | 2026-02-20 | English | ||
| 31899172 | 8-K Filing | 2026-02-12 | English | ||
| 13296055 | FORM 4/A | 2026-01-16 | English | ||
|
2025
1 filing
| |||||
| 13296058 | FORM 4 | 2025-11-17 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Axsome Therapeutics, Inc.
A biopharmaceutical company developing therapies for centra…
|
AXSM | US | Manufacturing |
|
AYTU BIOPHARMA, INC
A specialty pharma company developing novel therapeutics fo…
|
AYTU | US | Manufacturing |
|
Ayurcann
Award-winning post-harvest cannabis solution provider offer…
|
AYUR | CA | Manufacturing |
|
Azitra, Inc.
Clinical-stage biopharma company developing microbiome-base…
|
AZTR | US | Manufacturing |
|
Bachem Holding AG
A CDMO developing and manufacturing peptides and oligonucle…
|
BANB | CH | Manufacturing |
|
Bacil Pharma Ltd.
Manufactures generic pharmaceutical formulations across var…
|
524516 | IN | Manufacturing |
|
Bafna Pharmaceuticals Limited
Develops and manufactures WHO-GMP certified pharmaceutical …
|
BAFNAPH | IN | Manufacturing |
|
Bajaj Healthcare Limited
Develops and manufactures APIs, intermediates, and finished…
|
BAJAJHCARE | IN | Manufacturing |
|
Bal Pharma Ltd.
Develops and manufactures APIs and finished formulations fo…
|
BALPHARMA | IN | Manufacturing |
|
Barinthus Biotherapeutics plc.
Clinical-stage biopharma developing immunotherapies that gu…
|
BRNS | GB | Manufacturing |
Organon & Co. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31461/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31461 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31461 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31461 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31461}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Organon & Co. (id: 31461)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.